Clinical Trial Update: Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lisdexamfetamine for safety and effect in children with ADHD and autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Lisdexamfetamine (lisdexamfetamine dimesylate)

Snippet

Sponsor: JPM van Stralen Medicine Professional | Conditions: Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder | Phase 4 | Status: COMPLETED